Together, they will develop and commercialize game-changing Liquid Glycan Array (LiGA) reagents designed to enable high-throughput, multiplex profiling of protein-glycan interactions on cell surfaces.
Tag: 48Hour Discovery
AdvanCell and GlycoNet-supported startup 48Hour Discovery announce collaboration and exclusive licensing agreement
48Hour Discovery partners with AdvanCell to advance a peptide-based Lead-212 radioligand therapy program for oncology.
Finding the right molecule in a haystack of life–saving possibilities
Developing a new drug starts with identifying the molecule or “ligand” that can block the molecular target or “receptor” involved in a disease. Even with high throughput screening, finding that one functional ligand for a receptor from a haystack of millions of possible compounds is expensive, high–risk and time–consuming. Converting a promising target into a […]